Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Interest Expenses (2019 - 2025)

Rockwell Medical's Interest Expenses history spans 7 years, with the latest figure at $286000.0 for Q4 2025.

  • For Q4 2025, Interest Expenses fell 1.04% year-over-year to $286000.0; the TTM value through Dec 2025 reached $1.1 million, down 10.37%, while the annual FY2025 figure was $1.1 million, 10.37% down from the prior year.
  • Interest Expenses reached $286000.0 in Q4 2025 per RMTI's latest filing, roughly flat from $285000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.1 million in Q4 2023 to a low of $232000.0 in Q2 2024.
  • Average Interest Expenses over 5 years is $449000.0, with a median of $421000.0 recorded in 2023.
  • Peak YoY movement for Interest Expenses: surged 469.61% in 2021, then tumbled 73.92% in 2024.
  • A 5-year view of Interest Expenses shows it stood at $588000.0 in 2021, then fell by 25.34% to $439000.0 in 2022, then skyrocketed by 152.39% to $1.1 million in 2023, then crashed by 73.92% to $289000.0 in 2024, then fell by 1.04% to $286000.0 in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Interest Expenses are $286000.0 (Q4 2025), $285000.0 (Q3 2025), and $276000.0 (Q2 2025).